Testing baby spit to predict lung disease in preemies
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Infections, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests if germs in a premature baby's mouth and lungs can help predict bronchopulmonary dysplasia (a serious lung condition). Researchers will collect spit samples from babies born very early to see if the germs can warn doctors early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Born before 32 weeks and 6 days of pregnancy
- Staying in a participating newborn care unit
- Parent or guardian has health insurance through the French social security system or equivalent
- Parent or guardian understands the study and signs a consent form
- Baby is not receiving only comfort (palliative) care
- Parent or guardian is 18 or older and speaks French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a breath test to predict lung disease in very premature babies. It could help doctors start treatment earlier to prevent serious breathing problems.
This study looks at how the germs in a baby's gut and their immune system respond to bronchiolitis (a common lung infection). If your baby is under 12 months and gets bronchiolitis during the RSV season, their participation could help us understand why some babies get very sick and others don't.
This study looks at very premature babies (born before 26 weeks) to find early signs that might predict a lung condition called bronchopulmonary dysplasia. The goal is to help doctors identify which babies are at risk sooner, so they can provide better care.
This study helps doctors predict which very premature babies might develop bronchopulmonary dysplasia (a chronic lung condition common in preemies) by analyzing their early medical records. Better early prediction could help doctors plan treatment sooner.
This study uses ultrasound images of the lungs to see if doctors can predict which very premature babies will develop bronchopulmonary dysplasia (BPD)—a chronic lung condition common in extremely premature infants. The goal is to identify at-risk babies early so they can receive targeted treatment.
This study is testing whether a simple ultrasound of the lungs done right after birth can help predict a lung problem called bronchopulmonary dysplasia (BPD) in very early preterm babies. If successful, this could help doctors identify babies at high risk sooner and provide better care.
Hear when a new Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.